Oncternal Therapeutics (NASDAQ:ONCT) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report released on Monday. The firm issued a sell rating on the stock. Several other equities analysts have also issued reports on ONCT. HC Wainwright raised shares of Oncternal Therapeutics from a neutral rating to a buy rating and set […]

Related Keywords

,Cantor Fitzgerald ,Millennium Management ,Renaissance Technologies ,Vanguard Group Inc ,Oncternal Therapeutics Inc ,Pasadena Private Wealth ,Healthcare Of Ontario Pension Plan Trust Fund ,Oncternal Therapeutics ,Free Report ,Brookline Capital Management ,Get Free Report ,Ontario Pension Plan Trust Fund ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,